Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Cognizant Technology Solutions Corporation (CTSH) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cognizant Technology Solutions Corporation (CTSH) - free report >>
Image: Bigstock
Seeking Clues to Cognizant (CTSH) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Wall Street analysts expect Cognizant (CTSH - Free Report) to post quarterly earnings of $1.13 per share in its upcoming report, which indicates a year-over-year decline of 4.2%. Revenues are expected to be $5.06 billion, up 6.4% from the year-ago quarter.
The consensus EPS estimate for the quarter has undergone a downward revision of 1.2% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Bearing this in mind, let's now explore the average estimates of specific Cognizant metrics that are commonly monitored and projected by Wall Street analysts.
Analysts expect 'Revenue- Products and Resources' to come in at $1.28 billion. The estimate indicates a change of +9.8% from the prior-year quarter.
Based on the collective assessment of analysts, 'Revenue- Health Sciences' should arrive at $1.50 billion. The estimate indicates a year-over-year change of +7.2%.
Analysts predict that the 'Revenue- Financial services' will reach $1.49 billion. The estimate suggests a change of +6.9% year over year.
The average prediction of analysts places 'Revenue- Communications, Media and Technology' at $803.52 million. The estimate suggests a change of -0.1% year over year.
View all Key Company Metrics for Cognizant here>>>
Cognizant shares have witnessed a change of +8.2% in the past month, in contrast to the Zacks S&P 500 composite's +2.7% move. With a Zacks Rank #3 (Hold), CTSH is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>